Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Olland

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Methods (San Diego, Calif.)|August 25, 2004
Automated systems for protein crystallizationJoel Bard, Kimberly Ercolani, Kristine Svenson, et al.
Bioengineered|December 13, 2021
The eptinezumab:CGRP complex structure - the role of conformational changes in binding stabilizationLaurent David, Michelle Scalley-Kim, Andrea Olland, et al.
Communications Biology|March 11, 2026
Mechanistic basis for improved activity of Engineered AsCas12aLinnea Jansson-Fritzberg, Bryant Chica, Chrysa Latrick, et al.
Journal of Medicinal Chemistry|October 19, 2007
Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitorsAriamala Gopalsamy, Mengxiao Shi, Diane H Boschelli, et al.
The Journal of Biological Chemistry|June 25, 2013
Crystal structure of a human IκB kinase β asymmetric dimerShenping Liu, Yohann R Misquitta, Andrea Olland, et al.
Bioorganic & Medicinal Chemistry Letters|July 25, 2009
Benzo[c][2,7]naphthyridines as inhibitors of PDK-1Kyung-Hee Kim, Allan Wissner, Middleton B Floyd, et al.
European Journal of Medicinal Chemistry|January 16, 2010
The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)Thomas Nittoli, Russell G Dushin, Charles Ingalls, et al.
Journal of Medicinal Chemistry|September 18, 2009
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2010
Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeabilityMichael S Malamas, Albert Robichaud, Jim Erdei, et al.
Journal of Medicinal Chemistry|December 9, 2009
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Methods (San Diego, Calif.)|August 25, 2004
Automated systems for protein crystallizationJoel Bard, Kimberly Ercolani, Kristine Svenson, et al.
Bioengineered|December 13, 2021
The eptinezumab:CGRP complex structure - the role of conformational changes in binding stabilizationLaurent David, Michelle Scalley-Kim, Andrea Olland, et al.
Communications Biology|March 11, 2026
Mechanistic basis for improved activity of Engineered AsCas12aLinnea Jansson-Fritzberg, Bryant Chica, Chrysa Latrick, et al.
Journal of Medicinal Chemistry|October 19, 2007
Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitorsAriamala Gopalsamy, Mengxiao Shi, Diane H Boschelli, et al.
The Journal of Biological Chemistry|June 25, 2013
Crystal structure of a human IκB kinase β asymmetric dimerShenping Liu, Yohann R Misquitta, Andrea Olland, et al.
Bioorganic & Medicinal Chemistry Letters|July 25, 2009
Benzo[c][2,7]naphthyridines as inhibitors of PDK-1Kyung-Hee Kim, Allan Wissner, Middleton B Floyd, et al.
European Journal of Medicinal Chemistry|January 16, 2010
The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)Thomas Nittoli, Russell G Dushin, Charles Ingalls, et al.
Journal of Medicinal Chemistry|September 18, 2009
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2010
Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeabilityMichael S Malamas, Albert Robichaud, Jim Erdei, et al.
Journal of Medicinal Chemistry|December 9, 2009
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Pageof 3